Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) Selling, General & Administrative (2012 - 2026)

Updated

Harvard Apparatus Regenerative Technology's Selling, General & Administrative came in at $751,000 for Q2 2026, down 34.8% from $1.15 million a year earlier and down 28.1% from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Selling, General & Administrative (2012 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Harvard Apparatus Regenerative Technology reported Selling, General & Administrative of $3.83 million, down 14.0% year-over-year; for FY2025, it came in at $4.25 million, down 15.3% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 5.5% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $5.02 million in FY2024 (-12.1%), $5.71 million in FY2023 (+29.5%), $4.41 million in FY2022 (-37.4%) and $7.04 million in FY2021 (+116.3%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q4 2022.
  • Year-over-year, Selling, General & Administrative has declined for eight consecutive quarters, with an average decline of 12.1% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q4 2021 (growth of 594.3%), and the weakest in Q4 2022 (a decline of 86.0%).
  • Business Quant data shows HRGN's Selling, General & Administrative at $1.05 million (Q1 2026), $986,000 (Q4 2025) and $1.05 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Harvard Apparatus Regenerative Technology 38.50 Mn 35.01 Mn 23,000.00 751,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 751,000.00
Mar 31, 2026 1.05 Mn
Dec 31, 2025 986,000.00
Sep 30, 2025 1.05 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 1.07 Mn
Dec 31, 2024 1.08 Mn
Sep 30, 2024 1.15 Mn
Jun 30, 2024 1.69 Mn
Mar 31, 2024 1.11 Mn
Dec 31, 2023 1.14 Mn
Sep 30, 2023 1.17 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 2.38 Mn
Dec 31, 2022 749,000.00
Sep 30, 2022 711,000.00
Jun 30, 2022 1.05 Mn
Mar 31, 2022 1.90 Mn
Dec 31, 2021 5.33 Mn
Sep 30, 2021 572,000.00
API Access

Harvard Apparatus Regenerative Technology Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HRGN&period=max&api_key=YOUR_API_KEY